Agios Pharmaceuticals, Inc. (LON: 0HB0)

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,577	977	1,280	1,318	2,198	2,465
Market Cap Growth	66.83%	-23.69%	-2.87%	-40.02%	-10.83%	17.11%
Enterprise Value	278	352	504	360	1,937	2,144
Last Close Price	27.53	17.50	25.51	24.92	32.40	25.10
PE Ratio	3.13	-	-	1.11	-	-
PS Ratio	76.90	46.40	108.35	-	-	-
PB Ratio	1.55	1.53	1.40	1.38	7.51	5.10
P/TBV Ratio	1.55	1.53	1.40	1.38	7.51	5.10
EV/Sales Ratio	10.42	16.69	42.61	-	-	-
EV/FCF Ratio	-1.13	-	-	-	-	-
Debt / Equity Ratio	0.04	0.09	0.08	0.08	0.26	0.18
Asset Turnover	0.02	0.02	0.01	-	-	-
Inventory Turnover	13.70	21.65	-	-	-	-
Quick Ratio	8.44	11.49	12.54	17.17	6.07	6.25
Current Ratio	8.99	12.27	13.30	17.79	6.74	6.59
Return on Equity (ROE)	53.65%	-36.83%	-19.37%	-42.15%	-63.33%	-45.39%
Return on Assets (ROA)	-18.17%	-22.49%	-18.17%	-20.65%	-24.08%	-22.60%
Return on Capital (ROIC)	-19.20%	-23.65%	-18.88%	-24.98%	-33.35%	-27.42%
Earnings Yield	31.90%	-28.29%	-15.02%	89.89%	-10.91%	-12.60%
FCF Yield	-15.62%	-23.87%	-20.38%	-23.14%	-10.16%	-11.72%
Buyback Yield / Dilution	-3.17%	-1.57%	9.36%	12.39%	-15.01%	-4.49%
Total Shareholder Return	-3.17%	-1.57%	9.36%	12.39%	-15.01%	-4.49%

Source: S&P Capital IQ. Standard template. Financial Sources.